Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cancer:

Global cancer statistics, 2012. Torre LA et al. CA Cancer J Clin. (2015)

Metabolic syndrome and risk of cancer: which link? Mendonça FM et al. Metabolism. (2015)

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Ferlay J et al. Eur J Cancer. (2013)

Search results

Items: 1 to 20 of 3697125

1.

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.

Wei CM, Su YJ, Qin X, Ding JX, Liu Q, Song FM, Zong SH, Xu J, Zhou B, Zhao JM.

Cell Physiol Biochem. 2018 Jul 19;48(2):644-656. doi: 10.1159/000491892. [Epub ahead of print]

2.

Establishment and characterization of a novel cell line derived from a small cell neuroendocrine carcinoma of the anal canal.

Dizdar L, Drusenheimer J, Werner TA, Möhlendick B, Schütte SC, Esposito I, Filler T, Knoefel WT, Krieg A.

Neuroendocrinology. 2018 Jul 19. doi: 10.1159/000492222. [Epub ahead of print]

PMID:
30025411
3.

Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.

Qiu ZL, Wei WJ, Sun ZK, Shen CT, Song HJ, Zhang XY, Zhang GQ, Chen XY, Luo QY.

Cell Physiol Biochem. 2018 Jul 19;48(2):718-730. doi: 10.1159/000491898. [Epub ahead of print]

4.

Identifying prognostic factors for well-differentiated metastatic pancreatic neuroendocrine tumours (pNETs): A retrospective international multicenter cohort study.

Jimenez-Fonseca P, Krug S, Tamagno G, Fierro Maya F, Monleon Getino A, Rodriguez Casado CI, Costa F, de Herder WW, Jann H.

Neuroendocrinology. 2018 Jul 19. doi: 10.1159/000492223. [Epub ahead of print]

PMID:
30025389
5.

Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.

Sargazi A, Shiri F, Keikha S, Majd MH.

Colloids Surf B Biointerfaces. 2018 Jul 11;171:150-158. doi: 10.1016/j.colsurfb.2018.07.025. [Epub ahead of print]

PMID:
30025377
6.

Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.

Phuong PTT, Lee S, Lee C, Seo B, Park S, Oh KT, Lee ES, Choi HG, Shin BS, Youn YS.

Colloids Surf B Biointerfaces. 2018 Jul 10;171:123-133. doi: 10.1016/j.colsurfb.2018.07.016. [Epub ahead of print]

PMID:
30025374
7.

Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line.

Zaki I, Abdelhameid MK, El-Deen IM, Abdel Wahab AHA, Ashmawy AM, Mohamed KO.

Eur J Med Chem. 2018 Jul 7;156:563-579. doi: 10.1016/j.ejmech.2018.07.003. [Epub ahead of print]

PMID:
30025350
8.

Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.

Berardozzi S, Bernardi F, Infante P, Ingallina C, Toscano S, De Paolis E, Alfonsi R, Caimano M, Botta B, Mori M, Di Marcotullio L, Ghirga F.

Eur J Med Chem. 2018 Jul 9;156:554-562. doi: 10.1016/j.ejmech.2018.07.017. [Epub ahead of print]

PMID:
30025349
9.

Synthesis and evaluation of the cytotoxic activity of Furanaphthoquinones tethered to 1H-1,2,3-triazoles in Caco-2, Calu-3, MDA-MB231 cells.

Costa DCS, de Almeida GS, Rabelo VW, Cabral LM, Sathler PC, Alvarez Abreu P, Ferreira VF, Cláudio Rodrigues Pereira da Silva L, da Silva FC.

Eur J Med Chem. 2018 Jul 9;156:524-533. doi: 10.1016/j.ejmech.2018.07.018. [Epub ahead of print]

PMID:
30025347
10.

Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.

Antoszczak M, Urbaniak A, Delgado M, Maj E, Borgström B, Wietrzyk J, Huczyński A, Yuan Y, Chambers TC, Strand D.

Eur J Med Chem. 2018 Jul 10;156:510-523. doi: 10.1016/j.ejmech.2018.07.021. [Epub ahead of print]

PMID:
30025346
11.

Novel curcumin analogue hybrids: Synthesis and anticancer activity.

Wang JQ, Wang X, Wang Y, Tang WJ, Shi JB, Liu XH.

Eur J Med Chem. 2018 Jul 10;156:493-509. doi: 10.1016/j.ejmech.2018.07.013. [Epub ahead of print]

PMID:
30025345
12.

Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents.

Xu Y, Wu L, Rashid HU, Jing D, Liang X, Wang H, Liu X, Jiang J, Wang L, Xie P.

Eur J Med Chem. 2018 Jul 16;156:479-492. doi: 10.1016/j.ejmech.2018.07.028. [Epub ahead of print]

PMID:
30025344
13.

Design and synthesis of novel imidazo[4,5-b]pyridine based compounds as potent anticancer agents with CDK9 inhibitory activity.

Ghanem NM, Farouk F, George RF, Abbas SES, El-Badry OM.

Bioorg Chem. 2018 Jul 6;80:565-576. doi: 10.1016/j.bioorg.2018.07.006. [Epub ahead of print]

PMID:
30025343
14.

Thermal and non-thermal health effects of low intensity non-ionizing radiation: An international perspective.

Belpomme D, Hardell L, Belyaev I, Burgio E, Carpenter DO.

Environ Pollut. 2018 Jul 6;242(Pt A):643-658. doi: 10.1016/j.envpol.2018.07.019. [Epub ahead of print] Review.

PMID:
30025338
15.

Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms.

Berdeja J, Palandri F, Baer MR, Quick D, Kiladjian JJ, Martinelli G, Verma A, Hamid O, Walgren R, Pitou C, Li PL, Gerds AT.

Leuk Res. 2018 Jun 30;71:82-88. doi: 10.1016/j.leukres.2018.06.014. [Epub ahead of print]

PMID:
30025280
16.

Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.

Ogata K, Sei K, Saft L, Kawahara N, Porta MGD, Chapuis N, Yamamoto Y.

Leuk Res. 2018 Jul 10;71:75-81. doi: 10.1016/j.leukres.2018.07.009. [Epub ahead of print]

PMID:
30025279
17.

Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey.

Thrift-Perry M, Cabanes A, Cardoso F, Hunt KM, Cruz TA, Faircloth K.

Breast. 2018 Jun 18;41:93-106. doi: 10.1016/j.breast.2018.06.005. [Epub ahead of print] Review.

PMID:
30025274
18.

Treatment of the breast cancer by using low frequency electromagnetic fields and Mn(II) complex of a Schiff base derived from the pyridoxal.

Yadamani S, Neamati A, Homayouni-Tabrizi M, Beyramabadi SA, Yadamani S, Gharib A, Morsali A, Khashi M.

Breast. 2018 Jul 11;41:107-112. doi: 10.1016/j.breast.2018.07.001. [Epub ahead of print]

PMID:
30025273
19.

Incidence of childhood cancer in Costa Rica, 2000-2014: An international perspective.

Erdmann F, Li T, Luta G, Giddings BM, Torres Alvarado G, Steliarova-Foucher E, Schüz J, Mora AM.

Cancer Epidemiol. 2018 Jul 16;56:21-30. doi: 10.1016/j.canep.2018.07.004. [Epub ahead of print]

PMID:
30025251
20.

The population-based incidence and mortality of biliary tract cancer in Sweden.

Kilander C, Lagergren J, Ljung R, Sadr-Azodi O.

Cancer Epidemiol. 2018 Jul 16;56:14-20. doi: 10.1016/j.canep.2018.06.004. [Epub ahead of print]

PMID:
30025250

Supplemental Content

Loading ...
Support Center